Citation Impact
Citing Papers
Molecular imaging of hypoxia with radiolabelled agents
2009
Molecular imaging in drug development
2008 Standout
Targeting hypoxia in cancer therapy
2011 Standout
Establishing the Diagnosis of Lung Cancer
2013 Standout
PET in the management of locally advanced and metastatic NSCLC
2015
Regulation of cancer cell metabolism by hypoxia-inducible factor 1
2008 StandoutNobel
Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer
2012 StandoutNobel
Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non–small‐cell lung cancer patients
2012
Metabolic Tumor Width Parameters as Determined on PET/CT Predict Disease-free Survival and Treatment Response in Squamous Cell Carcinoma of the Esophagus
2008
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response
2009
Epidemiology of Parkinson's disease
2006 Standout
Incidence of Parkinson's Disease: Variation by Age, Gender, and Race/Ethnicity
2003 Standout
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Age-standardized incidence and prevalence of Parkinson's disease in a Swedish community
1996
Hypoxia in cancer: significance and impact on clinical outcome
2007 Standout
Breast cancer sentinel lymph node mapping using near-infrared guided indocyanine green in comparison with blue dye
2013
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
Methods for Staging Non-small Cell Lung Cancer
2013
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
Hypoxia-inducible factor 1 and breast cancer metastasis
2015 StandoutNobel
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Standardized Uptake Values in the Primary Lesions of Non-Small-Cell Lung Cancer in FDG-PET/CT Can Predict Regional Lymph Node Metastases
2015
Epidermal Growth Factor Receptor in Glioma: Signal Transduction, Neuropathology, Imaging, and Radioresistance
2010
Evaluation of HIF-1 inhibitors as anticancer agents
2007 StandoutNobel
Biomedical photoacoustic imaging
2011 Standout
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
European Organisation for Research and Treatment of Cancer Recommendations for Planning and Delivery of High-Dose, High-Precision Radiotherapy for Lung Cancer
2010
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
2008 StandoutNobel
Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006.
2007
Selective Killing of Hypoxia-Inducible Factor-1–Active Cells Improves Survival in a Mouse Model of Invasive and Metastatic Pancreatic Cancer
2009 StandoutNobel
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
In Vivo Photoacoustic Tomography of Chemicals: High-Resolution Functional and Molecular Optical Imaging at New Depths
2010
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Epidemiologic and Molecular Prognostic Review of Glioblastoma
2014 Standout
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 StandoutScience
Works of Guoren Yang being referenced
Hypoxia Imaging With 18F-Fluoroerythronitroimidazole Integrated PET/CT and Immunohistochemical Studies in Non–Small Cell Lung Cancer
2013
PET-Based Biodistribution and Radiation Dosimetry of Epidermal Growth Factor Receptor–Selective Tracer 11C-PD153035 in Humans
2009
Relationship between primary tumor fluorodeoxyglucose uptake and nodal or distant metastases at presentation in T1 stage non-small cell lung cancer
2008
Serial Hypoxia Imaging With 99mTc-HL91 SPECT to Predict Radiotherapy Response in Nonsmall Cell Lung Cancer
2006
Noninvasive Evaluation of Microscopic Tumor Extensions Using Standardized Uptake Value and Metabolic Tumor Volume in Non-Small-Cell Lung Cancer
2011
Diagnostic and Prognostic Value of 18F-FDG PET/CT for Patients with Suspected Recurrence from Squamous Cell Carcinoma of the Esophagus
2007
Bone metastasis in patients with non-small cell lung cancer: The diagnostic role of F-18 FDG PET/CT
2009
Preoperative Lymphoscintigraphy Predicts the Successful Identification but Is Not Necessary in Sentinel Lymph Nodes Biopsy in Breast Cancer
2007
Determining optimal clinical target volume margins on the basis of microscopic extracapsular extension of metastatic nodes in patients with non–small-cell lung cancer
2007
[Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer].
2008
Further characterization of the epidermal growth factor receptor ligand 11C-PD153035
2007
Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer.
2006